Annals of Nuclear Medicine

, Volume 15, Issue 5, pp 451–453 | Cite as

Tc-99m MIBI imaging in malignant fibrous histiocytoma

  • Cumali Aktolun
  • Fatma Berk
  • Hakan Demir
  • Cengiz Ercin
Case Reports


The authors report a case of malignant fibrous histiocytoma of the left forearm demonstrated by Tc-99m MIBI imaging. The tumor originated in the soft tissue of the forearm; no obvious bone invasion or metastasis was detected scintigraphically or radiologically.

Key words

malignant fibrous histiocytoma Tc-99m MIBI Tc-99m MDP bone scan 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Enginger ME, Weiss SW. Malignant fibrohistiocytic tumors. In:Soft Tissue Tumors. Enzinger ME, Weiss SW (eds), St. Louis; Mosby, Inc., 1998: 373–375.Google Scholar
  2. 2.
    Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201.Clin Nucl Med 1992; 17: 171–176.PubMedCrossRefGoogle Scholar
  3. 3.
    Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with Tc-99m sestamibi imaging: comparison with CT scan.Eur J Nucl Med 1994; 21: 973–976.PubMedGoogle Scholar
  4. 4.
    Aktolun C, Bayhan H, Ozturk E. Better visualisation of retinoblastoma metastases with Tc-99m SestaMibi versus Tl-201.Clin Nucl Med 1995; 20: 446–468.PubMedCrossRefGoogle Scholar
  5. 5.
    Aktolun C. Tc-99m sestamibi imaging in breast cancer: an alternative to Tl-201 imaging.J Nucl Med 1994; 35: 2055–2056.PubMedGoogle Scholar
  6. 6.
    Lin WY, Kao CH, Hsu CY, Liao SQ, Wag SJ, Yeh SH. The role of Tc-99m MDP and Ga-67 imaging in the clinical evaluation of Malignant fibrous histiocytoma.Clin Nucl Med 1994; 19: 996–1000.PubMedCrossRefGoogle Scholar
  7. 7.
    Harrowe DJ, Kessler S, Jansen AA, Larson SM. Gallium-67 uptake by a malignant fibrous histiocytoma: Case Report.J Nucl Med 1976; 17: 630–632.PubMedGoogle Scholar
  8. 8.
    Zazzaro PF, Bosworth JE, Schneidar V, Zelenah JJ. Gallium scaning in malignant fibrous histiocytoma.Am J Roentgenol 1980; 135: 775–779.Google Scholar
  9. 9.
    Mackey JK, Jackson BA, Fetters DV, Edwards SM, McBride JP, Cole RL, et al. Bone and Gallium scan findings in malignant fibrous histiocytoma. Case report with radiographic and pathologic correlation.Clin Nucl Med 1987; 12: 17–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Stemerman DH. The appearance of malignant fibrous histocytoma on a three-phase bone scan.Clin Nucl Med 1996; 21: 398–399.PubMedCrossRefGoogle Scholar
  11. 11.
    Sanders TG, Wilf LH, Northup HM. Case Report: Malignant fibrous histiocytoma: etiology for a cold defect on Tc-99m MDP scan.J Nucl Med 1990; 31: 1104–1105.PubMedGoogle Scholar
  12. 12.
    Taki J, Sumiya H, Asada N, Ueda Y, Tsuchiya H, Tonami N. Assessment of p-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.J Nucl Med 1998; 39: 1179–1184.PubMedGoogle Scholar
  13. 13.
    Spencer RP, Evans DD, Forouhar F, Fetters DV, Yeh SD. Tc-99m diphosphonate uptake in malignant fibrous histiocytoma: a possible iron-related effect.Clin Nucl Med 1988; 13: 734–735.PubMedCrossRefGoogle Scholar
  14. 14.
    Rosenthall C. Tc-99m methylenediphosphonate concentration in soft tissue malignant fibrous histiocytoma.Clin Nucl Med 1978; 3: 58–61.PubMedCrossRefGoogle Scholar
  15. 15.
    Tonami N, Itoh K, Yui N, Terusi S, Torizuka K. Clinical usefulness of thallium-201 chloride in the diagnosis of tumor(II): as evaluation in bone, soft tissue and mediastinal tumors.KAKU IGAKU (Jpn J Nucl Med) 1994; 31: 63–74.Google Scholar
  16. 16.
    Hayashi Y, Kimura N, Bandoh Y, Fujimoto N, Kohyama Y, Kumagai H. Intracerebral malignant fibrous histiocytoma with increased uptake on Tl-201 image.Clin Nucl Med 1996; 21: 1007.PubMedCrossRefGoogle Scholar
  17. 17.
    Sumiya H, Taki J, Tsuchiya H, Nonomura A, Miyauchi T, Tonami N. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.J Nucl Med 1998; 39: 1600–1604.PubMedGoogle Scholar
  18. 18.
    Sumiya H, Taki J, Tonami N, Asada N, Tsuchiya H, Tomita K. Evaluation of bone and soft tissue lesion using99mTc-MIBI: comparison with201Tl and the relation to chemotherapeutic effect.KAKU IGAKU (Jpn J Nucl Med) 1997; 34: 105–111.Google Scholar

Copyright information

© Springer 2001

Authors and Affiliations

  • Cumali Aktolun
    • 1
    • 2
  • Fatma Berk
    • 1
    • 2
  • Hakan Demir
    • 1
    • 2
  • Cengiz Ercin
    • 1
    • 2
  1. 1.Department of Nuclear MedicineKocaeli University School of MedicineKocaeliTurkey
  2. 2.Department of PathologyKocaeli University School of MedicineKocaeliTurkey

Personalised recommendations